Jerome Kim

Jerome Hahn Kim is Director General of the International Vaccine Institute (IVI).[1][2]

He was educated at University of Hawaiʻi at Mānoa where he studied Biology and History, the Yale School of Medicine (MD, 1984), and completed his training at Duke University Medical Center.[3][4] Prior to IVI, Dr. Kim led the US Army's advanced development program for HIV vaccines, the RV 144 HIV vaccine trial, and a molecular virology laboratory at Walter Reed Army Institute of Research.[3]

He has an h-index of 70 according to Google Scholar.[5]

References
  1. Ledford, Heidi (2021). "Why COVID vaccines are so difficult to compare". Nature. 591 (7848): 16–17. Bibcode:2021Natur.591...16L. doi:10.1038/d41586-021-00409-0. PMID 33623151. S2CID 232039872. Retrieved 15 July 2021.
  2. "India's Covid Curve Could Raise the World's". The Wall Street Journal. Retrieved 15 July 2021.
  3. "Scientific Advisory Board". Vaccitech. Retrieved 15 July 2021.
  4. "Jerome Kim Named to Head South Korea's International Vaccine Institute". John A. Burns School of Medicine. Retrieved 15 July 2021.
  5. "Jerome Kim". Google Scholar. Retrieved 15 July 2021.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.